News
Sin Stock Investing: Are There Opportunities Beyond Ethical Debate?
An updated edition of the Jan. 16, 2026, article.Sin stocks refer to shares of companies that operate in industries often considered socially controversial, such as alcohol, tobacco, gambling and
Clover Health Enters Collaboration to Be Part of CMS Aligned Network
Clover Health Investments CLOV has announced a partnership with healthcare’s leading communication network, Kno2, to become the first payer live on a CMS Aligned Network and TEFCA. This will enable
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
Cardinal Health CAH is well-positioned for continued growth, thanks to the expansion of its speciality portfolio. The firm delivered strong fiscal second-quarter results, fueled by robust demand in
Gorilla Technology Roars Past $100M Revenues With a $7B+ Pipeline
Gorilla Technology Group Inc. GRRR announced 2025 adjusted earnings per share (EPS) of 88 cents, decreasing from the year-ago level of $2.01. Yet, the full-year 2025 IFRS loss per share improved
Kroger Q4 Earnings Top Estimates, E-Commerce Sales Rise 20%
The Kroger Co. KR reported fourth-quarter fiscal 2025 results, wherein the bottom line surpassed the Zacks Consensus Estimate and improved year over year. The company also delivered modest sales
MongoDB Expands AI Capabilities: Is the Growth Thesis Strengthening?
MongoDB MDB is expanding its AI capabilities with a set of features designed to simplify how intelligent applications are built and deployed. The company has introduced new embedding models from
Sandisk Trades at 15.83x Discounted P/E: Time to Buy the Stock?
Sandisk SNDK currently trades at a forward 12-month price-to-earnings multiple of 15.83x, below the Zacks Computer-Storage Devices industry average of 17.03x and at a significant discount to the
Parade of Econ Data: Jobless Claims, Productivity & More
Thursday, March 5th, 2026Today’s pre-market is filled with plenty of economic data. Being a normal Thursday morning, we see new Weekly Jobless Claims, but also Productivity and Labor Costs as well
Nebius Boosts Infrastructure Expansion With 1.2GW AI Factory Approval
Nebius Group N.V. NBIS recently announced that the Independence City Council has approved the Chapter 100 industrial development incentive plan for its proposed AI factory campus in Independence
ASTS Rides on Expanding Partner Base: Will it Drive Revenue Growth?
AST SpaceMobile, Inc. ASTS recently announced that it has formed a collaboration with TELUS Corporation, a leading telecommunication service provider in Canada. TELUS will leverage ASTS’ robust
Verizon Shares Rise 19.4% in a Year: Should You Invest Now?
Verizon Communications Inc. VZ has gained 19.4% in the past year against the Wireless National industry’s decline of 2.1%. The stock has underperformed the Zacks Computer & Technology sector during
Nebius' 1.2 GW Win: A $20B Bet on AI Infrastructure
Shares of Nebius Group (NASDAQ: NBIS) have been rising in direct response to a monumental announcement that solidifies the company’s high-stakes pivot into the heart of the artificial
EVgo Q4 Loss Narrower Than Expected, Revenues Increase Y/Y
EVgo Inc. EVGO reported a loss of 4 cents per share for the fourth quarter of 2025 (ended Dec. 31), narrower than the loss of 11 cents reported in the year-ago quarter as well as the Zacks Consensus
DuPont Upgrades WAVE PRO Capabilities With RO and NI Tech
DuPont de Nemours, Inc. DD has expanded its advanced online water treatment modeling tool, WAVE PRO, by adding features of reverse osmosis (RO) and nanofiltration (NF). The enhanced solution
BASFY's Shanghai Plant Begins Production of Elastollan FR TPU
BASF SE BASFY recently announced that its thermoplastic polyurethane (TPU) facility in Shanghai has qualified to manufacture Elastollan Flame-Retardant TPU grade, expanding its portfolio of
ChargePoint Q4 Earnings Beat Estimates, Revenues Increase Y/Y
ChargePoint Holdings, Inc. CHPT reported a loss of 54 cents per share for the fourth quarter of fiscal 2026 (ended Jan. 31), narrower than the loss of $1.2 in the year-ago quarter. The reported
Here's Why You Should Retain Verisk Stock in Your Portfolio Now
Verisk Analytics, Inc. VRSK is bolstered by its tech-savvy initiatives, boosting the company’s prospects. Shareholder-friendly initiatives are encouraging. The company is grappling with elevated
Ulta Beauty (ULTA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Wall Street expects a year-over-year decline in earnings on higher revenues when Ulta Beauty (ULTA) reports results for the quarter ended January 2026. While this widely-known consensus outlook is
ServiceTitan Inc. (TTAN) Reports Next Week: Wall Street Expects Earnings Growth
The market expects ServiceTitan Inc. (TTAN) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended January 2026. This widely-known
Sunrise Realty Trust, Inc. (SUNS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Sunrise Realty Trust, Inc. (SUNS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This
Runway Growth Finance Corp. (RWAY) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Wall Street expects a year-over-year decline in earnings on lower revenues when Runway Growth Finance Corp. (RWAY) reports results for the quarter ended December 2025. While this widely-known
Rubrik, Inc. (RBRK) Expected to Beat Earnings Estimates: Should You Buy?
Rubrik, Inc. (RBRK) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended January 2026. This widely-known consensus outlook
Lifetime Brands (LCUT) Expected to Beat Earnings Estimates: Should You Buy?
Wall Street expects a year-over-year decline in earnings on lower revenues when Lifetime Brands (LCUT) reports results for the quarter ended December 2025. While this widely-known consensus outlook
Analysts Estimate Nektar Therapeutics (NKTR) to Report a Decline in Earnings: What to Look Out for
Nektar Therapeutics (NKTR) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus
Earnings Preview: Gossamer Bio (GOSS) Q4 Earnings Expected to Decline
The market expects Gossamer Bio (GOSS) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus